Litigation Details for Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)

Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)

Docket		Date Filed	2017-08-16
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To
Parties	APOTEX CORP.; APOTEX INC.; CEPHALON, INC.; EAGLE PHARMACEUTICALS, INC.; FRESENIUS KABI USA, LLC; MYLAN LABORATORIES LIMITED; SLAYBACK PHARMA LIMITED LIABILITY COMPANY; TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Patents	10,112,981; 10,188,728; 10,188,730; 10,188,745; 10,189,797; 10,215,746; 10,247,737; 10,280,430; 10,307,579; 10,334,848; 10,364,437; 10,369,409; 10,370,679; 10,375,981; 10,376,505; 10,376,564; 10,376,568; 10,376,579; 10,376,583; 10,376,601; 10,376,652; 10,376,658; 10,383,875; 10,383,918; 10,383,920; 10,383,923; 10,398,669; 10,398,730; 10,406,160; 10,406,332; 10,406,383; 10,407,434; 10,407,488; 10,413,505; 10,413,543; 10,413,564; 10,413,568; 10,413,569; 10,413,593; 10,420,723; 10,420,816; 10,420,838; 10,420,841; 10,488,413; 10,488,416; 10,519,226; 10,568,841; 10,568,908; 10,568,934; 10,597,432; 10,597,433; 10,597,434; 10,597,728; 10,624,875; 6,190,659; 6,268,399; 6,280,993; 6,340,695; 6,403,569; 6,405,764; 6,406,731; 6,416,999; 6,425,676; 6,436,713; 6,505,597; 6,562,793; 6,569,430; 6,579,968; 6,579,981; 6,623,959; 6,629,968; 6,652,394; 6,652,398; 6,652,921; 6,676,746; 6,682,904; 6,695,722; 6,695,723; 6,723,340; 6,726,918; 6,736,695; 6,740,669; 6,746,681; 6,747,189; 6,755,420; 6,764,419; 6,764,678; 6,793,959; 6,875,904; 6,899,648; 6,908,591; 6,923,737; 6,923,968; 6,923,984; 6,979,437; 6,979,829; 6,984,403; 6,987,103; 6,988,968; 6,991,394; 7,189,740; 7,223,554; 7,226,629; 7,226,793; 7,280,816; 7,320,968; 7,320,997; 7,323,623; 7,334,488; 7,334,695; 7,361,676; 7,364,736; 7,364,740; 7,371,408; 7,371,409; 7,374,747; 7,378,488; 7,410,664; 7,410,797; 7,427,602; 7,428,875; 7,432,265; 7,435,427; 7,435,755; 7,468,372; 7,473,543; 7,569,554; 7,572,448; 7,579,189; 7,579,473; 7,591,745; 7,597,901; 7,601,740; 7,601,746; 7,601,758; 7,654,921; 7,654,997; 7,658,918; 7,659,282; 7,678,399; 7,682,624; 7,713,737; 7,713,999; 7,718,425; 7,722,898; 7,728,190; 7,728,191; 7,731,648; 7,737,112; 7,745,409; 7,758,889; 7,816,323; 7,816,379; 7,816,383; 7,829,120; 7,829,320; 7,829,659; 7,838,504; 7,838,505; 7,838,564; 7,841,372; 7,847,486; 7,875,435; 7,875,664; 7,875,726; 7,879,334; 7,879,816; 7,887,844; 7,901,687; 7,915,247; 7,915,307; 7,923,432; 7,923,564; 7,942,764; 7,959,920; 7,959,942; 7,959,999; 7,968,569; 7,981,088; 7,981,416; 7,981,418; 7,981,889; 7,982,075; 7,982,077; 7,982,078; 7,985,408; 7,985,418; 7,985,745; 7,993,219; 7,993,222; 7,993,223; 7,993,629; 8,088,737; 8,088,934; 8,112,934; 8,112,942; 8,152,658; 8,188,844; 8,222,484; 8,226,505; 8,247,425; 8,268,847; 8,323,942; 8,361,959; 8,372,431; 8,372,432; 8,372,434; 8,372,624; 8,372,968; 8,376,993; 8,379,486; 8,383,655; 8,383,887; 8,398,993; 8,403,923; 8,409,579; 8,409,616; 8,419,722; 8,420,629; 8,420,674; 8,420,676; 8,425,934; 8,431,597; 8,435,505; 8,435,554; 8,435,942; 8,486,898; 8,486,981; 8,486,991; 8,486,993; 8,546,372; 8,546,409; 8,562,979; 8,562,981; 8,562,982; 8,568,713; 8,568,740; 8,568,747; 8,568,793; 8,568,979; 8,583,380; 8,591,899; 8,597,654; 8,597,655; 8,597,681; 8,597,713; 8,602,920; 8,616,723; 8,623,418; 8,623,591; 8,623,901; 8,623,920; 8,652,484; 8,658,676; 8,664,215; 8,669,245; 8,679,473; 8,679,569; 8,679,844; 8,695,189; 8,722,410; 8,722,679; 8,728,332; 8,728,519; 8,728,546; 8,728,730; 8,740,982; 8,747,847; 8,747,904; 8,753,679; 8,758,726; 8,758,816; 8,791,270; 8,829,175; 8,841,087; 8,841,125; 8,887,981; 8,889,190; 8,889,191; 8,889,600; 8,889,616; 8,889,722; 8,889,740; 8,889,831; 8,901,374; 8,901,378; 8,901,484; 8,915,889; 8,920,383; 8,921,374; 8,952,043; 8,968,724; 8,968,726; 8,968,753; 8,979,682; 8,981,064; 8,981,103; 8,987,421; 8,987,487; 8,987,554; 8,991,403; 8,993,250; 8,993,519; 8,993,624; 8,993,838; 8,999,340; 8,999,398; 8,999,728; 8,999,915; 9,066,942; 9,089,756; 9,092,952; 9,125,816; 9,125,889; 9,144,568; 9,226,934; 9,265,723; 9,265,737; 9,265,740; 9,265,758; 9,265,831; 9,265,887; 9,271,968; 9,282,745; 9,340,797; 9,364,436; 9,364,437; 9,370,629; 9,375,434; 9,376,505; 9,383,370; 9,403,904; 9,404,915; 9,408,746; 9,408,904; 9,408,979; 9,408,993; 9,409,987; 9,409,997; 9,416,371; 9,422,593; 9,433,219; 9,433,371; 9,433,624; 9,434,915; 9,434,997; 9,468,676; 9,468,682; 9,468,747; 9,468,829; 9,486,406; 9,486,408; 9,486,682; 9,488,654; 9,504,655; 9,504,669; 9,505,722; 9,505,841; 9,546,369; 9,546,372; 9,554,968; 9,562,904; 9,572,484; 9,572,797; 9,572,856; 9,572,887; 9,579,421; 9,593,374; 9,593,378; 9,597,374; 9,597,399; 9,597,409; 9,597,591; 9,597,659; 9,624,152; 9,624,307; 9,629,797; 9,629,831; 9,629,841; 9,629,847; 9,629,899; 9,629,920; 9,629,959; 9,655,979; 9,687,474; 9,687,581; 9,695,422; 9,695,428; 9,695,437; 9,713,543; 9,713,629; 9,718,841; 9,723,844; 9,724,323; 9,724,378; 9,724,380; 9,724,391; 9,724,394; 9,724,405; 9,724,410; 9,724,415; 9,726,669; 9,730,915; 9,730,934; 9,730,993; 9,737,399; 9,737,488; 9,737,554; 9,737,572; 9,737,591; 9,737,669; 9,745,334; 9,750,713; 9,750,726; 9,750,747; 9,750,793; 9,756,687; 9,758,829; 9,793,659; 9,797,901; 9,829,487; 9,841,424; 9,844,505; 9,844,581; 9,844,601; 9,844,655; 9,856,265; 9,856,320; 9,856,323; 9,889,144; 9,901,623; 9,901,629; 9,901,724; 9,915,659; 9,918,468; 9,918,654; 9,921,222; 9,952,219; 9,968,655; 9,968,658; 9,968,659; 9,968,674; 9,968,676; 9,981,041; 9,981,058; 9,981,087; 9,982,051; 9,987,271; 9,987,332; 9,987,334; 9,987,369; 9,987,416; 9,988,406; 9,988,422; 9,988,432; 9,988,437; 9,993,474; 9,993,554; 9,993,568; 9,999,593; 9,999,655
Attorneys	Adam D. Harber; Alex M. Grabowski; Anjali D. Deshmukh; Anna G. Phillips; Arun John Mohan; Ben V. Picozzi; Beth C. Finkelstein; Bobby Delafield; Brian E. Farnan; Constance S. Huttner; Damien Nicholas Tancredi; Daniel G. Brown; David A. Bilson; David I. Berl; David S. Steuer; Elise M. Baumgarten; Eve H. Ormerod; Frank D. Rodriguez; Helen H. Ji; Imron T. Aly; James Michael Lennon; James P. Barabas; Jeffrey A. Cohen; Jeremy S. Cole; John C. Phillips , Jr.; John D. Cravero; John W. Shaw; Karen Elizabeth Keller; Kenneth G. Schuler; Kevin M. Nelson; Marc N. Zubick; Martha C. Kidd; Matthew Lachman; Megan C. Haney; Michael J. Farnan; Michelle L. Ernst; Nathan Roger Hoeschen; Neal C. Belgam; Nicole W. Stafford; Rhyea Malik; Shaun P. Mahaffy; Sherry L. Rollo; Shyamkrishna Palaiyanur; Steven E. Feldman
Firms	Devlin Law Firm LLC; Farnan LLP; Flaster Greenburg, P.C.; Phillips, Goldman, McLaughlin & Hall, P.A.; Schiff Hardin LLP; Shaw Keller LLP; Smith, Katzenstein, & Jenkins LLP
Link to Docket	External link to docket

Biologic Drugs cited in Cephalon, Inc. v. Slayback Pharma Limited Liability Company

Details for Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-04-27	394	Opinion	Treanda®. Tr. 981:25−82:2, 1657:10−11. In 2015, Teva acquired Cephalon, Tr. 1660:10−14, and Cephalon…enablement under 35 U.S.C. § 112; and (4) claim 9 of the #797 patent is invalid for lack of written … and without the antioxidant, #831 patent at 12 Section 112(b) of Title 35 provides that “[t]he…#568 patent, and (2) July 10, 2012 for the remaining administration claims. D.I. 332; Tr. 2015:10-16.… at any temperature. Tr. 1485:4−87:10, 1502:8−12. And the patents provide a POSITA with a method for	External link to document
2020-07-06	406	Order - -Memorandum and Order	all the patents that were asserted in the case by Plaintiffs except for U.S. Patent No. 8,791,270. The …respectively, with the exception of U.S. Patent No. 8,791,270, which has been resolved by the granting… 8,791,270, which has been resolved by the granting of a consent judgment." D.I. 319 ,r 4. …of the patent that has been asserted by Slayback in this case, with the exception of U.S. Patent No. 8,791,270…either infringe the asserted patents or don't infringe the asserted patents. I note in this regard that	External link to document